SKINOVATION PHARMACEUTICAL INC

Overview

• IndustryBlank Checks¹
• HeadquartersSalt Lake City, Utah¹
• Incorporated inWY²
• Business address440 East 400 South, Ste 300, Salt Lake City, Ut 84111²
• Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company²

See how the biggest companies compare on our leaderboards

Most likely, management will seek to structure any such transaction so as not to require stockholder approval.³ From its latest annual report

What it owns

What SKINOVATION PHARMACEUTICAL INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Timeline

1. Mar 12, 20248-K Change of auditor⁹
2. Mar 4, 20248-K Change of auditor¹⁰

Filings

18 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 2 major events, 3 other. The latest 18:

1. Mar 31, 2025NT 10-K FORM 12B-25 EDGAR
2. Nov 21, 202410-Q EDGAR
3. Nov 18, 2024NT 10-Q FORM 12B-25 EDGAR
4. Aug 12, 202410-Q EDGAR
5. May 9, 202410-Q EDGAR
6. Apr 15, 202410-K EDGAR
7. Apr 2, 2024NT 10-K FORM 12B-25 EDGAR
8. Mar 12, 20248-K/A EDGAR
9. Mar 4, 20248-K EDGAR
10. Nov 2, 202310-Q EDGAR
11. Aug 3, 202310-Q EDGAR
12. May 3, 202310-Q EDGAR
13. Mar 30, 202310-K EDGAR
14. Nov 3, 202210-Q EDGAR
15. Aug 12, 202210-Q EDGAR
16. May 13, 202210-Q EDGAR
17. Mar 23, 202210-K EDGAR
18. Nov 10, 202110-Q EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How SKINOVATION PHARMACEUTICAL INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARSKINOVATION PHARMACEUTICAL INC¹
• CIK0001118072
• Employer ID (EIN)87-0458170¹
• Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company¹
• Incorporated inWyoming¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)6770 Blank Checks¹
• SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance¹
• Business address440 East 400 South, Ste 300, Salt Lake City, UT 84111¹
• Phone801-323-2395¹
• Shares outstanding708,000 as of Nov 19, 2024⁷
• Public float$0 as of Jun 30, 2023⁵
• On EDGAR sinceJul 11, 2000¹
• Filings113 in all: 10-Q (51), 10QSB (22), 10-K (17), 10KSB (7), 8-K (7), 8-K/A (3), NT 10-K (2), 10-K/A (1)¹
  All 11 form types

  10-Q/A (1), 10SB12G (1), NT 10-Q (1)

• Latest filingsAnnual report (10-K) Apr 15, 2024
  Quarterly report (10-Q) Nov 21, 2024
  Latest 8-K (8-K) Mar 4, 2024